Clinical Trial Update: Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation [NA]

View source ↗

Summary

The clinical trial evaluating dual-site botulinum toxin type A injections for lifelong premature ejaculation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• Botulinum toxin type A (OnabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Al Mouwasat Hospital | Conditions: Premature (Early) Ejaculation | NA | Status: COMPLETED